Author

Ron Litman

Jacob S. Sherkow is a Professor of Law at the Innovation Center for Law and Technology at New York Law School where he teaches a variety of courses related to intellectual property. His research focuses on how scientific developments, especially in the biosciences, affect patent law and litigation. Prof. Sherkow is the author of over 30 articles on these and related topics in both scientific journals and traditional law reviews, including Science, Nature, and the Yale Law Journal and the Stanford Law Review.
  • Health Law Policy

    Can Anesthesiologists Adopt a Public Health Law Framework to Improve Medication Safety?

    Anesthesiologists are the only type of healthcare provider that prescribes, dispenses, premixes, repackages, relabels, and administers the medications, independently and without secondary verification or use of technologic support.

    Can Anesthesiologists Adopt a Public Health Law Framework to Improve Medication Safety?

    By

    Ron Litman

    Image of healthcare professionals holding up an anesthesia mask up to you
  • FDA

    Should Non-opioid Analgesics have “Opioid Sparing” as a Label Claim?

    By Ron Litman Most meetings of the FDA’s Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) are held to review a New Drug Application (NDA), usually for a novel opioid preparation. But, on November 15,…

    Should Non-opioid Analgesics have “Opioid Sparing” as a Label Claim?

    By

    Ron Litman

    hand reaching for blue pills
  • FDA

    Commentary: Do We Really Need a New, More Powerful Opioid?

    By Ron Litman The FDA’s Analgesic and Anesthetic Drug Advisory Committee (AADPAC), of which I am a member, met October 12 to discuss a controversial New Drug Application (NDA) for a powerful opioid called sufentanil,…

    Commentary: Do We Really Need a New, More Powerful Opioid?

    By

    Ron Litman

    Scott Gottleib at a press conference